| dc.contributor |
MSF International, 37 Rue de la Tourelle, 1040 Brussels, Belgium. |
|
| dc.creator |
Kindermans, J M |
|
| dc.creator |
Matthys, F |
|
| dc.date |
2001-11 |
|
| dc.date.accessioned |
2017-01-31T07:09:28Z |
|
| dc.date.available |
2017-01-31T07:09:28Z |
|
| dc.identifier |
Introductory note: The access to Essential Medicines Campaign. 2001, 6 (11):955-6 Trop. Med. Int. Health |
|
| dc.identifier |
1360-2276 |
|
| dc.identifier |
11703852 |
|
| dc.identifier |
http://hdl.handle.net/10144/17668 |
|
| dc.identifier |
http://fieldresearch.msf.org/msf/handle/10144/17668 |
|
| dc.identifier |
Tropical Medicine & International Health |
|
| dc.identifier.uri |
http://dspace.mediu.edu.my:8181/xmlui/handle/10144/17668 |
|
| dc.description |
To ensure access to essential medicines for disadvantaged populations there are at least three conditions to be met: drugs prices must be affordable for poor countries; research and development of drugs for tropical diseases must take place; and there is a need for health exceptions to trade agreements. |
|
| dc.language |
en |
|
| dc.publisher |
Wiley-Blackwell |
|
| dc.relation |
http://www.blackwell-synergy.com/loi/tmi |
|
| dc.rights |
Archived on this site with the kind permission of Wiley-Blackwell |
|
| dc.title |
Introductory note: The access to Essential Medicines Campaign. |
|